Coming Soon

Oxford Drug Design specializes in providing drug discovery services and solutions through computational chemistry and molecular modeling. The company focuses on advancing pharmaceutical research by offering expertise in structure-based drug design, lead optimization, and molecular simulations to support the development of new therapeutic compounds.
Public Funding Received
Dual-target Enzyme Inhibitors to Combat Antibacterial Resistance
Collaborative R&D
2024-05-01
A Novel Veterinary-only Antibiotic for the Treatment of S. suis Infections in Pigs
Collaborative R&D
2021-12-01
The development of novel antibiotics for drug resistant infections
Collaborative R&D
2020-06-01
Continuity Grant support for Oxford Drug Design Uk-China AMR project
Feasibility Studies
2019-06-01
Novel tRNA synthetase inhibitors to treat drug resistant Gram-negative infections
Small Business Research Initiative
2019-06-01
Novel small molecule and TCM approaches to support pig production, minimizing generation of resistance to human antibiotics
Collaborative R&D
2017-03-01
Dual-target tRNA synthetase inhibitors for the treatment of drug-resistant bacterial infections
Collaborative R&D